# Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity

> **NCT02524184** · PHASE4 · UNKNOWN · sponsor: **Xiang Guang-da** · enrollment: 11 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** sildenafil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02524184
- **Lead sponsor:** Xiang Guang-da
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2016-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524184, "Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02524184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*